These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24813520)

  • 41. Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function.
    Philla KQ; Min SB; Hefner JN; Howard RS; Reinhardt BJ; Nazareno LG; Vogt KS
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1101-6. PubMed ID: 26024243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of topical swallowed steroids on the bacterial and fungal esophageal microbiota in eosinophilic esophagitis.
    Benitez AJ; Tanes C; Mattei L; Hofstaedter CE; Kim DK; Gross J; Ruffner MA; Albenberg L; Spergel J; Bittinger K; Muir AB
    Allergy; 2021 May; 76(5):1549-1552. PubMed ID: 32990947
    [No Abstract]   [Full Text] [Related]  

  • 43. A meta-analysis of efficacy of topical steroids in eosinophilic esophagitis: From the perspective of histologic, clinical, and endoscopic outcome.
    Hao LX; Lu Y; Li T; Gong B
    Gastroenterol Hepatol; 2021 Apr; 44(4):251-260. PubMed ID: 33162187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature.
    Warzecha J; Dziekiewicz M; Bieńkowska-Tokarczyk A; Małecki M; Banaszkiewicz A
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
    Rubinstein E; Hait EE; Mitchell PD; Lee JJ
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eosinophilic esophagitis.
    Aceves SS
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):145-59. PubMed ID: 25459582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allergy-test-driven elimination diet is useful in children with eosinophilic esophagitis, regardless of the severity of symptoms.
    Syrigou E; Angelakopoulou A; Zande M; Panagiotou I; Roma E; Pitsios C
    Pediatr Allergy Immunol; 2015 Jun; 26(4):323-9. PubMed ID: 25845555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low detection of adrenal suppression secondary to swallowed steroids for eosinophilic esophagitis in a quality improvement project.
    Kochis SR; Cooke DW; Dantzer J; Wood R; Keet C
    J Allergy Clin Immunol Pract; 2020; 8(10):3647-3649.e3. PubMed ID: 32668294
    [No Abstract]   [Full Text] [Related]  

  • 49. Histologic response to steroids in eosinophilic esophagitis is dependent on delivery compound.
    Schupack DA; Johnson K; Akambase JA; Geno D; Lavey C; Lennon RJ; Ravi K; Snyder DL; Katzka DA; Alexander JA
    Dis Esophagus; 2022 Dec; 36(1):. PubMed ID: 35780320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.
    Andrist CM; Jörg L; Greuter T; Gschwend A; Straumann A; Helbling A
    BMC Gastroenterol; 2020 Dec; 20(1):419. PubMed ID: 33308158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticosteroids for Eosinophilic Esophagitis in Children: A Meta-analysis.
    Munoz-Osores E; Maldonado-Campos I; Olivares-Labbe MT; Villarroel L; Gana JC
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33115796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical Management of Eosinophilic Esophagitis in Pediatric Patients.
    Ruffner MA; Juste L; Muir AB
    Pediatr Clin North Am; 2021 Dec; 68(6):1191-1204. PubMed ID: 34736584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study.
    Greuter T; Godat A; Ringel A; Almonte HS; Schupack D; Mendoza G; McCright-Gill T; Dellon ES; Hirano I; Alexander J; Chehade M; Safroneeva E; Bussmann C; Biedermann L; Schreiner P; Schoepfer AM; Straumann A; Katzka DA
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2514-2523.e2. PubMed ID: 32798703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis.
    Philpott H; Dougherty MK; Reed CC; Caldwell M; Kirk D; Torpy DJ; Dellon ES
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1071-1078. PubMed ID: 29508432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
    Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
    J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eosinophilic esophagitis: review of nonsurgical treatment modalities.
    Reddy V; Ghaffari G
    Allergy Asthma Proc; 2013; 34(5):421-6. PubMed ID: 23998238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophilic esophagitis in children.
    Trivedy P; Teitelbaum JE
    Paediatr Drugs; 2015 Jun; 17(3):227-37. PubMed ID: 25792526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Food allergy and eosinophilic esophagitis: what do we do?
    Chehade M; Aceves SS; Furuta GT; Fleischer DM
    J Allergy Clin Immunol Pract; 2015; 3(1):25-32. PubMed ID: 25577614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging therapies for eosinophilic esophagitis.
    Meek PD; Hemstreet B
    Pharmacotherapy; 2023 Apr; 43(4):338-348. PubMed ID: 36840634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy.
    Stuck MC; Straumann A; Simon HU
    Allergy; 2011 May; 66(5):705-7. PubMed ID: 21470243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.